Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar

Published 23/01/2023, 16:14
© Reuters.  Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar
IXIC
-
KALA
-

Benzinga - Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.

High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard and some other stocks to watch moving up the list.

Kala Phamaceuticals (NASDAQ: KALA): Clinical stage biopharmaceutical company Kala tops the leaderboard for the second straight week. Data shows 36.9% of the float short, up from last week’s 36.3% figure. The cost to borrow on shares is 288%, down from last week’s 378.2%. Shares of the Watertown, Massachusetts-based company recently soared after the FDA accepted its investigational new drug application.

PaxMedica Inc (NASDAQ: PXMD): The Tarrytown, New York-based biopharmaceutical company moves up one position to second place for this week’s short squeeze leaderboard. Data shows 30.5% of the float short, in line with last week’s figure. The cost to borrow on shares is 810.9% this week, up from last week’s 660% and one of the highest seen in recent weeks.

Getty Images Holdings (NYSE: GETY): The content creator and image marketplace company has been a frequent short squeeze candidate since going public via SPAC merger. The stock moves down one position on the leaderboard to third place. Data shows 100% of the float short and a cost to borrow of 141.8%, both figures similar to last week’s 99.9% and 141.8% respectively.

Related Link: A Massive Short Squeeze Is Underway: Bed Bath And A Few Favorites Are In Play

MicroStrategy Inc (NASDAQ: MSTR): The Tysons, Virginia-based software company is a frequent target of short sellers due to its high exposure to leading cryptocurrency Bitcoin (CRYPTO: BTC). MicroStrategy moves up one position on the leaderboard to fourth place. Data shows 36.5% of the float short and a cost to borrow of 38.8%.

Avalon GloboCare Corp (NASDAQ: ALBT): The healthcare management company ranks fifth on this week’s short squeeze leaderboard, moving down one position from last week. Data shows 18.3% of the float short and a cost to borrow of 15.2%.

Stocks to Watch: The five candidates listed above were all the same from the previous week’s leaderboard, with some slight changes to the order. Here are several other stocks to watch making big moves up the leaderboard that could crack the top five in the coming weeks.

Professional Diversity Network (NASDAQ: IPDN): Short interest is 7.7% of float and a cost to borrow of 13.1%. The stock moves up 57 positions to rank seventh place for the week.

Huadi International Group (NASDAQ: HUDI): Short interest of 9.9% and a cost to borrow of 88.1%. Stock moves up 40 positions to rank 11th for the week.

Kura Sushi (NASDAQ: KRUS): Short interest of 27.9% of the float and a cost to borrow of 3.1%. The stock moves up 50 positions to rank 16th for the week.

Read Next: GameStop Short Squeeze Anniversay: A Look Back At David Vs. Goliath Battle And What' Next

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.